Sign in / Join Now
ETFs & Funds
Enanta Pharmaceuticals Is Simply Too Cheap To Ignore $
Add a reply...
Latest StockTalks »
people get ENTA breaking news and analysis by email alert.
Get email alerts on ENTA »
Enanta Pharmaceuticals, Inc.
Get latest price
From other sites
Enanta Pharmaceuticals To Present At The Credit Suisse 25th Annual Healthcare Conference
at TheStreet (Wed, 7:30AM)
Enanta Pharmaceuticals Announces New Data Presentations At The Liver Meeting® 2016
at TheStreet (Oct 3, 2016)
Enanta Pharmaceuticals Announces AbbVie's Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation
at TheStreet (Sep 30, 2016)
Enanta Pharmaceuticals Presents Data On A Novel Non-Fusion Inhibitor Of Respiratory Syncytial Virus (RSV) At The 10th Annual Respiratory Syncytial Virus Conference
at TheStreet (Sep 29, 2016)
Enanta Pharmaceuticals Initiates Phase 1 Clinical Study Of EDP-305, Its Lead FXR Agonist For The Treatment Of Non-alcoholic Steatohepatitis (NASH)
at TheStreet (Sep 28, 2016)